Page 139 - Journal of Special Operations Medicine - Spring 2017
P. 139

(continues)








                  Pharmacology  85% renal clearance; 7%–10% bile/stool clearance Significantly reduced clearance in renal failure  Hepatic metabolism (active metabolites)  Renal excretion (85%, 80% unchanged)  Onset: <1 hour PO, 5–10 minutes IV  Selective serotonin 5-HT 3  receptor antagonist  Specific benzodiazepine receptor antagonist Resedation may occur 20–60 minutes after initial dose,





                     Onset <5 minutes.  Active metabolites. Duration of action: 1–4 hours  IM dose variable and delayed   Oxycodone  Hepatic metabolism  Active metabolites  Urinary excretion Duration of effect: 4–6 hours  Acetaminophen (see below)  Onset: 1–5 minutes Duration of effect: 1–4 hours  Renal excretion  Anticholinergic  Rapid onset Duration of effect: 2–6 hours  Duration of effect: 4–6 hours  Hepatic metabolism  Renal excretion  Hepatic metabolism Excreted in the u







                     –  –  –  –  –  –  –  –  –  –  –  –  –  –  –  –  –  –  –  –  –  –  –  –  –  –   –  –  –  –







                  Side-Effects and Notes Respiratory/cardiac/mental status depression  Anticholinergic like effects, particularly urinary   Respiratory/cardiac/mental status depression  Liver toxicity (acetaminophen) at high doses or if  compromised liver function at baseline Respiratory/cardiac/mental status depression  Personnel and equipment needed for standard  respiratory resuscitation should be available during  midazolam administration.  Increased serum transaminases A















                        Nausea/vomiting     Pruritus (itching)     Constipation        retention     Nausea/vomiting     Pruritus (itching)     Constipation     Hypersensitivity (rare)           Amnestic     Nausea/vomiting     Hypotension     Constipation        Tachycardia/palpitations     Nausea/vomiting     Flushing     Urinary retention     Not to exceed 4 doses/d     Hypersensitivity (rare)        Nausea/vomiting (IV)        to 4,000mg        Constipation     Dizziness/
                     –  –  –  –  –  –  –  –  –  –  –  –  –  –  –  –  –  –  –  –  –  –  –  –  –  –  –  –  –  –  –  –









                  Purpose/Dose Breakthrough pain in hemodynamically stable patient:  IV/IO/ IN: dose every 5 minutes until goal achieved or RR   Nonintubated: 2.5–10mg  IM: not preferred; can give 5–10mg IM if necessary Contains oxycodone (5mg) AND acetaminophen (325mg) PO/enteral (may be crushed): 1–2 tabs every 4–6 hours. DO NOT exceed 4,000mg total acetaminophen per day.  Sedation (includes anxiety or agitation): IV/IO: dose every 5 minutes until goal achieved or RR <   An









               Appendix D  Cont.  Name  < 10/min.  •   Intubated: 5–10mg   •   Morphine**  Background pain  •   Percocet  10/min.  Nonintubated: 0.5–2mg  •   Intubated: 1–4mg  •   (Versed)  Midazolam   IM: not recommended  ketamine)  SC/IM/IV/IO: 0.1–0.2mg every 4 hours  •   (Robinul)  Glycopyrrolate  For mild to moderate pain:  (Tylenol)  Acetaminophen  For nausea and vomiting:  •   •   are not improved  (Zofran)     Odansatron  •   Flumazenil  (Romazicon)










              Guidelines: Analgesia and Sedation During PFC                                                  115
   134   135   136   137   138   139   140   141   142   143   144